Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nadine E Struckman

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Frontiers in Immunology|March 28, 2025
Mutated <i>DNMT3A</i> creates a public HLADQ- binding neoantigen on acute myeloid leukemiaDyantha I van der Lee, Eva M Argiro, Sebastiaan N J Laan, et al.
Leukemia|September 15, 2025
Resolving inter- and intra-patient heterogeneity in NPM1-mutated AML at single-cell resolutionE Onur Karakaslar, Eva M Argiro, Nadine E Struckman, et al.
Biomedicines|May 25, 2024
Hotspot DNA Methyltransferase 3A (<i>DNMT3A</i>) and Isocitrate Dehydrogenase 1 and 2 (<i>IDH1/2</i>) Mutations in Acute Myeloid Leukemia and Their Relevance as Targets for ImmunotherapyNadine E Struckman, Rob C M de Jong, M Willy Honders, et al.
Leukemia|December 13, 2025
A T-cell receptor targeting RUNX1 frameshift mutations in acute myeloid leukemiaNadine E Struckman, Georgia Koutsoumpli, Rob C M de Jong, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Frontiers in Immunology|March 28, 2025
Mutated <i>DNMT3A</i> creates a public HLADQ- binding neoantigen on acute myeloid leukemiaDyantha I van der Lee, Eva M Argiro, Sebastiaan N J Laan, et al.
Leukemia|September 15, 2025
Resolving inter- and intra-patient heterogeneity in NPM1-mutated AML at single-cell resolutionE Onur Karakaslar, Eva M Argiro, Nadine E Struckman, et al.
Biomedicines|May 25, 2024
Hotspot DNA Methyltransferase 3A (<i>DNMT3A</i>) and Isocitrate Dehydrogenase 1 and 2 (<i>IDH1/2</i>) Mutations in Acute Myeloid Leukemia and Their Relevance as Targets for ImmunotherapyNadine E Struckman, Rob C M de Jong, M Willy Honders, et al.
Leukemia|December 13, 2025
A T-cell receptor targeting RUNX1 frameshift mutations in acute myeloid leukemiaNadine E Struckman, Georgia Koutsoumpli, Rob C M de Jong, et al.
Pageof 1